Pregnant women's choices for preventing respiratory syncytial virus (RSV)
Vaccine,
Год журнала:
2025,
Номер
unknown, С. 126790 - 126790
Опубликована: Янв. 1, 2025
Respiratory
syncytial
virus
(RSV)
is
the
leading
cause
of
bronchiolitis
and
pneumonia
in
infants
can
lead
to
severe
respiratory
distress,
especially
very
young
infants.
No
specific
treatments
exist
for
RSV.
However,
new
preventative
strategies
have
become
available
including
RSV
vaccine
pregnant
women
monoclonal
antibody
This
study
aimed
identify
understand
barriers
facilitators
uptake
a
determine
their
underlying
choices
maternal
immunisation
program.
Additionally,
investigated
choice
vaccination
or
administration
long-lasting
Eligible
participants
were
residing
Australia
aged
18
years
older.
Focus
group
discussions
individual
online
interviews
conducted
data
analysed
using
thematic
analysis
approach.
A
total
34
participated
focus
interviews,
with
an
average
age
years.
The
identified
themes
categorised
into
four
overarching
domains:
1)
motivators
vaccinating
during
pregnancy
safeguard
babies
prevent
diseases,
2)
safety
concerns,
uncertainties
regarding
effectiveness,
hesitancy
arising
from
COVID-19
experiences,
3)
preferred
promotion
strategies,
constant
reminders/prompts,
personalised
messages,
campaign
focusing
on
serious
outcomes
diverse/lay
languages,
recommendations
local
obstetricians
health
authorities,
4)
clear
recommendation
policies
preference
over
infant
immunisation.
was
generally
welcomed
by
our
comparing
other
strategies.
Preferences
program
included
diversity
"nudge"
reminders,
healthcare
providers.
Язык: Английский
Knowledge and Attitudes Regarding Respiratory Syncytial Virus (RSV) Prevention: A Systematic Review
Vaccines,
Год журнала:
2025,
Номер
13(2), С. 159 - 159
Опубликована: Фев. 6, 2025
Background:
New
strategies
for
respiratory
syncytial
virus
(RSV)
prevention
are
available
and
in
development,
but
their
acceptance
is
crucial
to
effectiveness.
Objectives:
This
systematic
review
aims
summarize
current
quantitative
qualitative
evidence
regarding
knowledge
attitudes
relating
RSV
prevention.
Methods:
Six
databases
(PubMed,
Scopus,
APA
PsycArticles;
PsycInfo;
CINAHL
Complete;
Psychology
Behavioral
Sciences
Collection)
two
preprint
repositories
(medRxiv
Preprints)
were
searched
up
until
23
December
2024
(PROSPERO:
CRD42024602351).
Results:
Sixty-one
articles
included,
focusing
on
vaccination
the
elderly
adults
at
risk
(n
=
10)
or
pregnant
people
24,
of
which
8
also
examined
preferences
maternal
vs.
infant
immunization)
immunization
27,
16
focused
palivizumab,
with
6
adherence
its
monthly
administration).
Eighteen
assessed
healthcare
professionals.
Overall,
findings
showed
limited
awareness
generally
positive
towards
moderate
high
intentions
uptake
rates.
Protection
against
disease
perceived
severity
promoted
acceptance,
whereas
concerns
about
side
effects
hindered
it.
Maternal
was
more
acceptable
than
immunization.
Conclusions:
Attitudes
options
favorable.
Should
become
available,
may
depend
characteristics,
how
they
framed
presented.
These
insights
highlight
importance
education
grounded
decision-making
literature,
while
recognizing
likely
favorable
reception
preventive
measures
across
target
age-populations.
Язык: Английский
Attitude to RSV Vaccination among a Cohort of Pregnant Women in Jordan
Опубликована: Июль 15, 2024
The
recently
approved
maternal
vaccination
against
respiratory
syncytial
virus
(RSV)
can
reduce
its
burden
among
infants.
Vaccine
hesitancy/resistance
undermine
the
beneficial
impact
of
RSV
vaccination.
aim
this
study
was
to
assess
willingness
pregnant
women
in
Jordan
receive
and
associated
determinants.
Face-to-face
interviews
were
conducted
obstetrics/gynecology
clinics
during
January-February
2024,
with
convenience
sampling.
Attitude
assessed
using
previously
validated
ABCDEF
scale.
A
total
404
participated
a
mean
age
30
years.
majority
participants
showed
(n=313,
77.5%),
hesitancy
25
(6.2%),
resistance
66
(16.3%).
Variables
that
signifi-cantly
higher
vaccine
acceptance
multivariate
analysis
were:
Язык: Английский